氟尿嘧啶-话题@MedSci

#氟尿嘧啶#

28篇内容 | 2223人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2218091, encodeId=e663221809158, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a> <a href='/topic/show?id=02982402298' target=_blank style='color:#2F92EE;'>#二线治疗#</a> <a href='/topic/show?id=a9ef83546d6' target=_blank style='color:#2F92EE;'>#胆道癌#</a> <a href='/topic/show?id=f01411e4629b' target=_blank style='color:#2F92EE;'>#亚叶酸钙#</a> <a href='/topic/show?id=e23f11e463b0' target=_blank style='color:#2F92EE;'>#纳米脂质体伊利替康#</a>, objectTitle=LANCET GASTROENTEROL | II期NALIRICC研究：研究结果不支持将纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸钙作为胆道癌二线治疗方案, objectType=article, longId=837244, objectId=0f1883e244de, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240802/1722564859167_92910.png, objectUrl=/article/show_article.do?id=0f1883e244de, replyNumber=0, likeNumber=57, createdTime=2024-08-02, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0f1883e244de, moduleTitle=LANCET GASTROENTEROL | II期NALIRICC研究：研究结果不支持将纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸钙作为胆道癌二线治疗方案, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0f1883e244de)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2191436, encodeId=ce55219143629, content=<a href='/topic/show?id=c3f910342343' target=_blank style='color:#2F92EE;'>#鼻咽癌#</a> <a href='/topic/show?id=10dc3890e66' target=_blank style='color:#2F92EE;'>#吉西他滨#</a> <a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a> <a href='/topic/show?id=231c10011915' target=_blank style='color:#2F92EE;'>#顺铂#</a>, objectTitle=姜新教授：同步放化疗后辅助顺铂-吉西他滨与顺铂-氟尿嘧啶治疗N2-3期鼻咽癌, objectType=article, longId=816145, objectId=2f7881614511, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/hospital-staff-doctor-review-PTX6YZP.jpg, objectUrl=/article/show_article.do?id=2f7881614511, replyNumber=0, likeNumber=110, createdTime=2024-03-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=2f7881614511, moduleTitle=姜新教授：同步放化疗后辅助顺铂-吉西他滨与顺铂-氟尿嘧啶治疗N2-3期鼻咽癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2f7881614511)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2184827, encodeId=ffb5218482eae, content=<a href='/topic/show?id=493ae869206' target=_blank style='color:#2F92EE;'>#结直肠癌#</a> <a href='/topic/show?id=43ca4456198' target=_blank style='color:#2F92EE;'>#奥沙利铂#</a> <a href='/topic/show?id=18c6256e1ba' target=_blank style='color:#2F92EE;'>#伊立替康#</a> <a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a> <a href='/topic/show?id=bc0e110695d0' target=_blank style='color:#2F92EE;'>#SCT200#</a>, objectTitle=转移性结直肠癌客观缓解率超30%！新疗法为患者带来又一选择, objectType=article, longId=811473, objectId=fba08114e399, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medical-conference-P42ZDP5.jpg, objectUrl=/article/show_article.do?id=fba08114e399, replyNumber=0, likeNumber=106, createdTime=2024-01-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fba08114e399, moduleTitle=转移性结直肠癌客观缓解率超30%！新疗法为患者带来又一选择, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fba08114e399)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1542865, encodeId=5fd41542865a7, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, objectType=article, longId=221344, objectId=e1b922134447, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e1b922134447, replyNumber=0, likeNumber=81, createdTime=2021-12-02, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e1b922134447, moduleTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e1b922134447)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542864, encodeId=ad451542864c4, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！, objectType=article, longId=219153, objectId=574821915388, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=574821915388, replyNumber=0, likeNumber=133, createdTime=2021-10-25, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=574821915388, moduleTitle=Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=574821915388)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542863, encodeId=494c15428634b, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, objectType=article, longId=217301, objectId=986821e3019a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=986821e3019a, replyNumber=0, likeNumber=132, createdTime=2021-09-20, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=986821e3019a, moduleTitle=J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=986821e3019a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542862, encodeId=fe751542862ce, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, objectType=article, longId=216219, objectId=7cde216219cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7cde216219cc, replyNumber=0, likeNumber=115, createdTime=2021-08-25, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7cde216219cc, moduleTitle=Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7cde216219cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542861, encodeId=55b41542861d7, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=J Clin Oncol：吉西他滨联合顺铂较氟尿嘧啶联合顺铂改善复发性或转移性鼻咽癌患者的预后: III期研究GEM20110714最终OS分析, objectType=article, longId=215670, objectId=64082156e056, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=64082156e056, replyNumber=0, likeNumber=128, createdTime=2021-08-14, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=64082156e056, moduleTitle=J Clin Oncol：吉西他滨联合顺铂较氟尿嘧啶联合顺铂改善复发性或转移性鼻咽癌患者的预后: III期研究GEM20110714最终OS分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=64082156e056)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542860, encodeId=ead81542860ff, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Eur Urol：前列腺特异性膜抗原和氟尿嘧啶转运体基因与原发性前列腺癌的不同临床特征和分子亚型有关 , objectType=article, longId=210652, objectId=f4f92106522f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4f92106522f, replyNumber=0, likeNumber=166, createdTime=2021-05-01, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4f92106522f, moduleTitle=Eur Urol：前列腺特异性膜抗原和氟尿嘧啶转运体基因与原发性前列腺癌的不同临床特征和分子亚型有关 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4f92106522f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542859, encodeId=cd55154285994, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Gastric Cancer：3期| 氟尿嘧啶/噻哌啶治疗转移性胃食管交界癌的疗效, objectType=article, longId=208434, objectId=55c3208434b1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=55c3208434b1, replyNumber=0, likeNumber=98, createdTime=2021-03-17, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=55c3208434b1, moduleTitle=Gastric Cancer：3期| 氟尿嘧啶/噻哌啶治疗转移性胃食管交界癌的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=55c3208434b1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542858, encodeId=e6611542858d7, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性, objectType=article, longId=198495, objectId=ee0919849563, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ee0919849563, replyNumber=0, likeNumber=94, createdTime=2020-08-02, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ee0919849563, moduleTitle=Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ee0919849563)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542857, encodeId=7c88154285edd, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=NEJM：氟尿嘧啶诱导的色素沉着-病例报道, objectType=article, longId=186675, objectId=d3731866e516, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d3731866e516, replyNumber=0, likeNumber=134, createdTime=2020-01-25, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d3731866e516, moduleTitle=NEJM：氟尿嘧啶诱导的色素沉着-病例报道, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d3731866e516)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542856, encodeId=4579154285635, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=JAMA Oncol：VALENTINO研究：帕尼单抗一线维持治疗RAS野生型结直肠癌劣于帕尼单抗联合氟尿嘧啶, objectType=article, longId=175430, objectId=98161e54306c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98161e54306c, replyNumber=0, likeNumber=0, createdTime=2019-07-16, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98161e54306c, moduleTitle=JAMA Oncol：VALENTINO研究：帕尼单抗一线维持治疗RAS野生型结直肠癌劣于帕尼单抗联合氟尿嘧啶, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98161e54306c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542855, encodeId=4047154285517, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=J Cataract Refract Surg：向前房内填充5-氟尿嘧啶实现角膜移植术成功治疗上皮向内生长, objectType=article, longId=167410, objectId=306916e4101b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=306916e4101b, replyNumber=0, likeNumber=0, createdTime=2019-06-02, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=306916e4101b, moduleTitle=J Cataract Refract Surg：向前房内填充5-氟尿嘧啶实现角膜移植术成功治疗上皮向内生长, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=306916e4101b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542854, encodeId=be42154285433, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Oncol：多西紫杉醇、顺铂和氟尿嘧啶联合化疗用于晚期肛门鳞状细胞癌, objectType=article, longId=142337, objectId=41ec14233e9b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=41ec14233e9b, replyNumber=0, likeNumber=84, createdTime=2018-07-05, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=41ec14233e9b, moduleTitle=Lancet Oncol：多西紫杉醇、顺铂和氟尿嘧啶联合化疗用于晚期肛门鳞状细胞癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=41ec14233e9b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542853, encodeId=fb531542853d9, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=EUR J Cancer：口服氟尿嘧啶联合吉西他滨治疗胰腺癌的患者生活质量, objectType=article, longId=131019, objectId=343a131019b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=343a131019b7, replyNumber=0, likeNumber=73, createdTime=2018-03-02, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=343a131019b7, moduleTitle=EUR J Cancer：口服氟尿嘧啶联合吉西他滨治疗胰腺癌的患者生活质量, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=343a131019b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542852, encodeId=b742154285294, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=J Gastroen Hepatol：口服氟嘧啶与静脉5-氟尿嘧啶治疗晚期胃癌和结直肠癌, objectType=article, longId=129559, objectId=b94f12955988, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b94f12955988, replyNumber=0, likeNumber=105, createdTime=2018-02-12, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b94f12955988, moduleTitle=J Gastroen Hepatol：口服氟嘧啶与静脉5-氟尿嘧啶治疗晚期胃癌和结直肠癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b94f12955988)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542851, encodeId=e0a3154285198, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Lancet Gastroen Hepatol：III级结肠癌患者的辅助治疗——氟尿嘧啶S1vs卡培他滨, objectType=article, longId=117531, objectId=fad311e53132, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fad311e53132, replyNumber=0, likeNumber=80, createdTime=2017-10-27, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fad311e53132, moduleTitle=Lancet Gastroen Hepatol：III级结肠癌患者的辅助治疗——氟尿嘧啶S1vs卡培他滨, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fad311e53132)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542850, encodeId=ce311542850b6, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Ophthal Plast Reconstr Surg：完善眼睑痉挛的美容性眼轮匝肌切除术：局部使用5-氟尿嘧啶和纤维蛋白粘合剂！, objectType=article, longId=112092, objectId=16401120923d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16401120923d, replyNumber=0, likeNumber=69, createdTime=2017-09-07, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16401120923d, moduleTitle=Ophthal Plast Reconstr Surg：完善眼睑痉挛的美容性眼轮匝肌切除术：局部使用5-氟尿嘧啶和纤维蛋白粘合剂！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16401120923d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1542849, encodeId=967f1542849de, content=<a href='/topic/show?id=64fe63923be' target=_blank style='color:#2F92EE;'>#氟尿嘧啶#</a>, objectTitle=Cochrane Db Syst Rev:氟尿嘧啶：口服用药和静脉给药，疗效有区别吗？, objectType=article, longId=107933, objectId=45aa10e933dd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=45aa10e933dd, replyNumber=0, likeNumber=98, createdTime=2017-08-08, rootId=0, userName=12498710m15暂无昵称, userId=a8ca13497099, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=45aa10e933dd, moduleTitle=Cochrane Db Syst Rev:氟尿嘧啶：口服用药和静脉给药，疗效有区别吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=45aa10e933dd)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

氟尿嘧啶

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#氟尿嘧啶# #二线治疗# #胆道癌# #亚叶酸钙# #纳米脂质体伊利替康#

LANCET GASTROENTEROL | II期NALIRICC研究：研究结果不支持将纳米脂质体伊立替康联合氟尿嘧啶和亚叶酸钙作为胆道癌二线治疗方案

2024-08-02发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#鼻咽癌# #吉西他滨# #氟尿嘧啶# #顺铂#

姜新教授：同步放化疗后辅助顺铂-吉西他滨与顺铂-氟尿嘧啶治疗N2-3期鼻咽癌

2024-03-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#结直肠癌# #奥沙利铂# #伊立替康# #氟尿嘧啶# #SCT200#

转移性结直肠癌客观缓解率超30%！新疗法为患者带来又一选择

2024-01-30发表于上海

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期

2021-12-02

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Lancet Oncol：脂质体伊立替康联合亚叶酸和氟尿嘧啶或可成为晚期胆道癌的二线标准治疗方案！

2021-10-25

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

J Clin Oncol：氟尿嘧啶/亚叶酸联合帕尼单抗维持治疗可显著延长RAS野生型转移性结直肠癌患者的生存期

2021-09-20

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Eur J Cancer：铂类+5-氟尿嘧啶+西妥昔单抗可作为中国复发/转移性头颈鳞癌患者的新一线治疗方案！

2021-08-25

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

J Clin Oncol：吉西他滨联合顺铂较氟尿嘧啶联合顺铂改善复发性或转移性鼻咽癌患者的预后: III期研究GEM20110714最终OS分析

2021-08-14

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Eur Urol：前列腺特异性膜抗原和氟尿嘧啶转运体基因与原发性前列腺癌的不同临床特征和分子亚型有关

2021-05-01

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Gastric Cancer：3期| 氟尿嘧啶/噻哌啶治疗转移性胃食管交界癌的疗效

2021-03-17

12498710m15暂无昵称 (审核中...)

前往app查看评论内容

#氟尿嘧啶#

Oral Dis：改良多西他赛加顺铂和5-氟尿嘧啶（TPF）在中国SCCHN患者中的疗效和安全性

2020-08-02

12498710m15暂无昵称 (审核中...)